The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study-Reference-Cited by-同舟云学术

The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study

Published:2021-03-09 Issue:11 Volume:25 Page:2823-2834
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Famularo Simone^ORCID,Donadon Matteo,Cipriani Federica,Ardito Francesco,Iaria Maurizio,Carissimi Francesca,Perri Pasquale,Dominioni Tommaso,Zanello Matteo,Conci Simone,Molfino Sarah,D’Acapito Fabrizio,Germani Paola,Ferrari Cecilia,Patauner Stefan,Pinotti Enrico,Sciannamea Ivano,Garatti Marco,Lodo Enrico,Troci Albert,Delvecchio Antonella,Floridi Antonio,Bernasconi Davide Paolo,Fumagalli Luca,Chiarelli Marco,Memeo Riccardo,Crespi Michele,Zanus Giacomo,Zimmitti Giuseppe,Antonucci Adelmo,Zago Mauro,Frena Antonio,Griseri Guido,Tarchi Paola,Ercolani Giorgio,Baiocchi Gian Luca,Ruzzenente Andrea,Jovine Elio,Maestri Marcello,Grazi GianLuca,Valle Raffaele Dalla,Giuliante Felice,Aldrighetti Luca,Romano Fabrizio,Torzilli Guido,Costa Guido,Ciulli Cristina,Giani Alessandro,Ratti Francesca,Bellobono Manuela,Cremaschi Elena,Valsecchi Maria Grazia,De Peppo Valerio,Calabrese Francesco,DeSario Giuseppina,Lazzari Giovanni,Cucchetti Alessandro,Cosola Davide,Percivale Andrea,Ciola Michele,Montuori Mauro,Frassani Silvia,Manzoni Alberto,Salvador Luca,Pennacchi Luca,Corleone Pio,Conticchio Maria,Torzilli Guido,

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s11605-021-04952-z.pdf

Reference41 articles.

1. Torzilli G. No-Mortality Liver Resection for Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients. Archives of Surgery 1999;134:984. https://doi.org/10.1001/archsurg.134.9.984.

2. Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y, et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 2009;144:46–51.

3. Famularo S, Donadon M, Cipriani F, Ardito F, Carissimi F, Perri P, et al. Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience. Updates Surg 2020. https://doi.org/10.1007/s13304-020-00733-6.

4. Kikuchi Y, Hiroshima Y, Matsuo K, Kawaguchi D, Murakami T, Yabushita Y, et al. A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma. Ann Surg Oncol 2016;23:3727–35.

5. Hammond JS, Guha IN, Beckingham IJ, Lobo DN. Prediction, prevention and management of postresection liver failure. Br J Surg 2011;98:1188–200.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma;World Journal of Surgical Oncology;2024-05-03

2. Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II study;International Journal of Surgery Protocols;2023-12-18

3. Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma;2023-12-16

4. Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach;Surgical Endoscopy;2023-12-05

5. Protocol to evaluate the efficacy and safety of tolvaptan in patients with ascites effusion after liver resection: An open-label, single-arm phase I/II study;2023-05-23